Palisade Bio, Inc. (PALI) stock
PALINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.01−0.02 (-1.94%)
Close on Nov 17, 2026Market cap $176.01MP/E –Yield –
Palisade Bio total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Palisade Bio's total debt was $87.00K at Dec 31, 2021. For fiscal 2021 it was $87.00K, down 92.4% from the year before. The highest annual figure on record is $8.79M in fiscal 2014.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $87.00K | -92.4% |
| FY2020 | Dec 31, 2020 | $1.14M | -69.2% |
| FY2016 | Dec 31, 2016 | $3.71M | -53.3% |
| FY2015 | Dec 31, 2015 | $7.93M | -9.8% |
| FY2014 | Dec 31, 2014 | $8.79M | +14.1% |
| FY2013 | Dec 31, 2013 | $7.70M | – |
| FY2012 | Dec 31, 2012 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2021 | Dec 31, 2021 | $87.00K | -96.6% |
| Q3 FY2021 | Sep 30, 2021 | $568.00K | -84.7% |
| Q2 FY2021 | Jun 30, 2021 | $1.14M | -76.4% |
| Q4 FY2020 | Dec 31, 2020 | $1.14M | – |
| Q1 FY2017 | Mar 31, 2017 | $2.53M | – |
| Q4 FY2016 | Dec 31, 2016 | $3.71M | – |
| Q3 FY2016 | Sep 30, 2016 | $4.83M | – |
See a number that looks wrong?